Skip to product information
1 of 1

GeneBio Systems

Recombinant Human Vitronectin/VTN (N-Truncated, C-6His)

Recombinant Human Vitronectin/VTN (N-Truncated, C-6His)

SKU:PKSH033866

Regular price ¥29,200 JPY
Regular price Sale price ¥29,200 JPY
Sale Sold out
Shipping calculated at checkout.

Size: 50μg

Storage: Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.

Shipping: This product is provided as lyophilized powder which is shipped with ice packs.

Exp date: 12 months

Category ID_II: Recombinant Proteins

Category ID_III: Cytokines

Abbreviation: Vitronectin;VTN

Target Synonym: Complement S-protein;S-protein;Serum Spreading Factor;Serum-spreading factor;Somatomedin B;V75;VN;VNT;VTN;Vitronectin;epibolin

Research Areas: Cardiovascular,Immunology

Conjugation:

Target Species: Human

Expression Host: HEK293 Cells

Application:

Fusion tag: C-His

UNIProt ID: P04004

Accession: AAH05046.1

Background: Vitronectin, also known as VTN, is a large glycoprotein found in blood and the extracellular matrix (ECM). Vitronectin is a plasma glycoprotein implicated as a regulator of diverse physiological process, including blood coagulation, fibrinolysis, pericellular proteolysis, complement dependent immune responses, and cell attachment and spreading. Blocking of Hic(a member of the pneumococcal surface protein C (PspC) family) by specific antiserum or genetic deletion significantly reduced pneumococcal binding to soluble and immobilised vitronectin and to Factor H, respectively. In addition, Vitronectin interact with glycosaminoglycans and proteoglycans. Is recognized by certain members of the integrin family and serves as a cell-to-substrate adhesion molecule. Inhibitor of the membrane-damaging effect of the terminal cytolytic complement pathway.

Concentration:

Activity: Not validated for activity

Sequence: Val62-Leu478

Purity: > 90 % as determined by reducing SDS-PAGE.

Formulation: Lyophilized from a 0.2 μm filtered solution of 20 mMTris-HCl,5% Mannitol,50 mM NaCl,0.02% Tween 80,pH8.0
Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the printed manual.

Reconstitution: Please refer to the printed manual for detailed information.

Endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method.

Calculated MW: 48.3 kDa

ObservedMW: 60-70 kDa

View full details